# The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients

> **NCT04600219** · — · UNKNOWN · sponsor: **Ai Peng** · enrollment: 250 (estimated)

## Conditions studied

- Hemodialysis Complication

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04600219
- **Lead sponsor:** Ai Peng
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04600219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04600219, "The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04600219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*